About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
R
KU ASCO 2019 Updates on Pancreatic Cancer: Maintenance Olaparib and Gemcitabine Adjuvant Therapy
By
KU Hematology & Medical Oncology Review 2019
FEATURING
Raed Al-Rajabi
By
KU Hematology & Medical Oncology Review 2019
FEATURING
Raed Al-Rajabi
839 views
August 21, 2019
0 Comments
Login to view comments.
Click here to Login
Featured Video
20:00
Exelixis
Child-Pugh Classification and its Role in Treatment Decisions in Pat…
Feat.
P. Gholam
Featured Video
15:07
Exelixis
Safety and Efficacy Data of a TKI Monotherapy in HCC
Feat.
J. Mizrahi
Related Content
AUTOPLAY
ON
27:37
ASCO GI 2023 Conference Coverage
ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates
Feat.
N. Uboha,
A. Turk,
K. Spencer,
M. Cecchini
23:58
ASCO GI 2023 Conference Coverage
ASCO GI 2023 Key Studies
Feat.
R. Kim,
R. Mehta
20:07
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Summary: "GI Expert Panel Discussion on Key Trials I…
Feat.
Y. Janjigian,
S. Cytryn,
S. Maron
08:34
Yale Cancer Center
NORPACT-1 Trial Updates: Neoadjuvant FOLFIRINOX vs. Upfront Surgery …
Feat.
J. Lacy
06:47
UCSF School of Medicine
Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+…
Feat.
H. Kang
06:03
Total Health
2024 Updates on Targeted Approaches for GI Cancers and New Data in N…
Feat.
A. Grothey
03:50
UCLA Health
Perspectives on the Recent FDA Approval of NALIRIFOX in Frontline Me…
Feat.
Z. Wainberg
39:04
2023 Johns Hopkins Updates in Gastrointestinal Cancers
Localized Pancreatic Cancer Controversial Cases: Panel Discussion
Feat.
M. Katz,
A. De Jesus-Acosta,
N. Zaidi,
J. He,
A. Narang,
T. Bekaii-Saab
12:08
Yale Cancer Center
GI Oncology Year in Review: Precision Medicine Update in Metastatic …
Feat.
J. Lacy
07:53
Total Health
Updates on Pancreatic Cancer - 2023 ASCO® Direct Philadelphia
Feat.
D. Lin
30:55
2023 Johns Hopkins Updates in Gastrointestinal Cancers
Medical Oncology Updates in Pancreas Cancer
Feat.
T. Bekaii-Saab
34:01
MedNews Week
Latest Treatment Strategies and Standard of Care for Pancreatic Canc…
Feat.
M. Pishvaian
06:28
Shubham Pant
FDA Approval of Liposomal Irinotecan/NALIRIFOX in 1L Metastatic Panc…
17:05
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "A Multicenter, Randomized, Open-Label, Thr…
Feat.
A. Ohba
22:10
Yale Cancer Center
Pancreatic Cancer Updates From Yale Cancer Center
Feat.
J. Lacy
08:08
Integrity Continuing Education
Updates in Nonmetastatic Upper-GI Adenocarcinoma
Feat.
J. Hernandez
25:56
OncoAlert
Year in Review: Pancreatic Cancers
Feat.
M. Lewis
10:53
Yale Cancer Center
GI Oncology Year in Review: Metastatic Pancreatic Cancer - NAPOLI-3 …
Feat.
J. Lacy
18:35
Rachna Shroff
Augmenting Standard Treatment Options in Pancreatic Cancer
15:25
Scripps MD Anderson Cancer Center
Pancreatic Cancer Trials - Evolving Landscape and Treatment Guidance
Feat.
J. Hecht
